Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Gynecology

Free Subscription Articles published in Gynecol Endocrinol Retrieve available abstracts of 212 articles: HTML format

Single Articles

December 2023
1. SUN H, Yuan M, Wang X, Jiao X, et al
   Clinical efficacy and safety of trimonthly administration of goserelin acetate 10.8 mg in premenopausal Chinese females with symptomatic adenomyosis: a prospective cohort study.
   Gynecol Endocrinol. 2023;39:2160435.
   PubMed     Abstract available
   
   
   
2. SHEIDA A, Davar R, Tabibnejad N, Eftekhar M, et al
   The effect of adding L-Carnitine to the GnRH-antagonist protocol on assisted reproductive technology outcome in women with polycystic ovarian syndrome: a randomized clinical trial.
   Gynecol Endocrinol. 2023;39:1878135.
   PubMed     Abstract available
   
   
   
3. HU L, Liu Y, Dong P, Ye P, et al
   Protective effect of wuzibushen recipe on follicular development via regulating androgen receptor in polycystic ovary syndrome model rats.
   Gynecol Endocrinol. 2023;39:2190808.
   PubMed     Abstract available
   
   
   
4. HOSSEINI E, Mokhtari Z, Salehi Abargouei A, Mishra GD, et al
   Maternal circulating leptin, tumor necrosis factor-alpha, and interleukine-6 in association with gestational diabetes mellitus: a systematic review and meta-analysis.
   Gynecol Endocrinol. 2023;39:2183049.
   PubMed     Abstract available
   
   
   
5. RUAN X
   Expert consensus on fertility preservation in hematopoietic stem cell transplantation in girls in China.
   Gynecol Endocrinol. 2023;39:2146671.
   PubMed     Abstract available
   
   
   
6. CUI S, Zhu X, Li S, Zhang C, et al
   Study on the predictive value of serum hypersensitive C-reactive protein, homocysteine, fibrinogen, and omentin-1 levels with gestational diabetes mellitus.
   Gynecol Endocrinol. 2023;39:2183046.
   PubMed     Abstract available
   
   
   March 2023
7. ARYEE NA, Adu-Bonsaffoh K, Arko-Boham B, Quaye O, et al
   Thyroid hormone profile in preeclampsia patients: a case control study.
   Gynecol Endocrinol. 2023 Mar 16:2186136. doi: 10.1080/09513590.2023.2186136.
   PubMed     Abstract available
   
   
   
8. NAPPI RE, Tiranini L, Bosoni D, Cucinella L, et al
   Women's attitudes about combined hormonal contraception (CHC) - induced menstrual bleeding changes - influence of personality traits in an Italian clinical sample.
   Gynecol Endocrinol. 2023 Mar 14:2189971. doi: 10.1080/09513590.2023.2189971.
   PubMed     Abstract available
   
   
   
9. MATEMANOSAK P, Peeyananjarassri K, Suwanrath C, Wattanakumtornkul S, et al
   Ovarian steroid cell tumor (not otherwise specified) with subsequent spontaneous pregnancy after tumor removal: a case report and literature review.
   Gynecol Endocrinol. 2023 Mar 6:2186138. doi: 10.1080/09513590.2023.2186138.
   PubMed     Abstract available
   
   
   February 2023
10. YU F, Xue Y, Zhao Y, Zhang L, et al
    Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats.
    Gynecol Endocrinol. 2023 Feb 26:2183045. doi: 10.1080/09513590.2023.2183045.
    PubMed     Abstract available
    
    
    
11. LIANG Y, Xu ML, Gao X, Wang Y, et al
    Resveratrol improves ovarian state by inhibiting apoptosis of granulosa cells.
    Gynecol Endocrinol. 2023 Feb 23:2181652. doi: 10.1080/09513590.2023.2181652.
    PubMed     Abstract available
    
    
    
12. SHU M, Yao S, Zhong W, Song C, et al
    Personalized embryo transfer based on RNA sequencing endometrial receptivity test in repeated implantation failure patients: artificial cycle versus natural cycle.
    Gynecol Endocrinol. 2023 Feb 23:2181639. doi: 10.1080/09513590.2023.2181639.
    PubMed     Abstract available
    
    
    
13. ZHANG Y, Zhou H, Ding C
    The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/beta-catenin pathway.
    Gynecol Endocrinol. 2023 Feb 23:2181637. doi: 10.1080/09513590.2023.2181637.
    PubMed     Abstract available
    
    
    
14. WEI J, Cheng P, Kong M, Zhang L, et al
    MicroRNA-23a-3p overexpression represses proliferation and accelerates apoptosis of granular cells in polycystic ovarian syndrome by targeting HMGA2.
    Gynecol Endocrinol. 2023 Feb 21:2172155. doi: 10.1080/09513590.2023.2172155.
    PubMed     Abstract available
    
    
    
15. YANG X, Xiaoping W, Nan D, Jian Z, et al
    Proteomic and bioinformatic analysis of human endometrium from polycystic ovarian syndrome with and without insulin resistance.
    Gynecol Endocrinol. 2023 Feb 7:2173948. doi: 10.1080/09513590.2023.2173948.
    PubMed     Abstract available
    
    
    
16. VANNUCCINI S, Petraglia F
    Adenomyosis: is an endocrine-related uterine dysfunction?
    Gynecol Endocrinol. 2023 Feb 3:2172156. doi: 10.1080/09513590.2023.2172156.
    PubMed    
    
    
    January 2023
17. YANG H, Chen Y, Liu C
    Triglyceride-glucose index is associated with metabolic syndrome in women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2023 Jan 28:2172154. doi: 10.1080/09513590.2023.2172154.
    PubMed     Abstract available
    
    
    
18. VON STOCKUM S, Becker K, Bauerfeind A, Franke C, et al
    NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study.
    Gynecol Endocrinol. 2023 Jan 23:1-5. doi: 10.1080/09513590.2023.2166032.
    PubMed     Abstract available
    
    
    
19. ZHENG R, Lin C, Mao Y, Jin F, et al
    miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis.
    Gynecol Endocrinol. 2023 Jan 19:2166483. doi: 10.1080/09513590.2023.2166483.
    PubMed     Abstract available
    
    
    
20. ZHANG H, Chen Z, Wang X
    Differentiated serum levels of Kruppel-like factors 2 and 4, sP-selectin, and sE-selectin in patients with gestational diabetes mellitus.
    Gynecol Endocrinol. 2023 Jan 19:1-4. doi: 10.1080/09513590.2022.2164762.
    PubMed     Abstract available
    
    
    
21. ZHONG M, Tu Y, Peng X, Song Y, et al
    A case of polycystic ovary syndrome with inevitable miscarriage and multi-site venous thrombosis caused by hereditary protein C deficiency.
    Gynecol Endocrinol. 2023 Jan 12:1-5. doi: 10.1080/09513590.2022.2162034.
    PubMed     Abstract available
    
    
    
22. VON STOCKUM S, Bauerfeind A, Becker K, Franke C, et al
    NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study.
    Gynecol Endocrinol. 2023 Jan 8:1-6. doi: 10.1080/09513590.2022.2162036.
    PubMed     Abstract available
    
    
    
23. BESTEL A, Elmas B, Gunkaya OS, Bestel M, et al
    Could sestrin protein in serum be a new marker of oxidative stress in patients with polycystic ovary syndrome?
    Gynecol Endocrinol. 2023 Jan 4:1-5. doi: 10.1080/09513590.2022.2163234.
    PubMed     Abstract available
    
    
    
24. WEN Y, Fan L, Pang L, Zhao T, et al
    NeiyiKangfu tablets control the progression of endometriosis through inhibiting RAF/MEK/ERK signal pathway by targeting RKIP.
    Gynecol Endocrinol. 2023 Jan 2:1-11. doi: 10.1080/09513590.2022.2162495.
    PubMed     Abstract available
    
    
    December 2022
25. BAKIRCI S, Sagsoz N, Devrim T, Sahin Y, et al
    Effect of ondansetron for preventing of ovarian hyperstimulation syndrome: in an experimental rat model.
    Gynecol Endocrinol. 2022 Dec 29:1-4. doi: 10.1080/09513590.2022.2163233.
    PubMed     Abstract available
    
    
    
26. ARTAR G, Tas B, Turan G, Uckan HH, et al
    Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS).
    Gynecol Endocrinol. 2022 Dec 29:1-5. doi: 10.1080/09513590.2022.2162496.
    PubMed     Abstract available
    
    
    
27. XU Z, Zhao H, Yue C, Zhang L, et al
    Low STING expression promotes endometrial stromal cell invasion and migration via the STING/IRF-3/IFN-beta1 pathway in eutopic endometrium of women with endometriosis.
    Gynecol Endocrinol. 2022 Dec 12:1-7. doi: 10.1080/09513590.2022.2154338.
    PubMed     Abstract available
    
    
    
28. PEREZ-LOPEZ FR, Lopez-Baena MT, Perez-Roncero GR, Chedraui P, et al
    Asprosin levels in women with and without the polycystic ovary syndrome: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2022 Dec 8:1-11. doi: 10.1080/09513590.2022.2152790.
    PubMed     Abstract available
    
    
    
29. MORETTI C, Lazzarin N, Vaquero E, Dal Lago A, et al
    A practical approach to the management of thyroid dysfunction during pregnancy.
    Gynecol Endocrinol. 2022 Dec 8:1-7. doi: 10.1080/09513590.2022.2154337.
    PubMed     Abstract available
    
    
    
30. PERALTA S, Solernou R, Barral Y, Roca J, et al
    Antral follicle count measured at down-regulation as predictor of ovarian response and cumulative live birth: single center analysis including 2731 long agonist IVF cycles.
    Gynecol Endocrinol. 2022 Dec 7:1-8. doi: 10.1080/09513590.2022.2154339.
    PubMed     Abstract available
    
    
    
31. HOSSEIN RASHIDI B, Shahrokh Tehraninejad E, Amanpour S, Bandarian F, et al
    The impact of letrozole on oocyte quality in assisted reproductive technology (ART); a randomized double-blind clinical trial.
    Gynecol Endocrinol. 2022;38:1087-1092.
    PubMed     Abstract available
    
    
    
32. JIAO G, Lian H, Xing J, Chen L, et al
    MOS mutation causes female infertility with large polar body oocytes.
    Gynecol Endocrinol. 2022;38:1158-1163.
    PubMed     Abstract available
    
    
    
33. UNANYAN A, Pivazyan L, Krylova E, Eskin A, et al
    Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis.
    Gynecol Endocrinol. 2022;38:1035-1046.
    PubMed     Abstract available
    
    
    November 2022
34. WANG Y, Ma R, Zou Y, Wang W, et al
    The role of obstetrician-gynecologists and reproductive endocrinologists in the blood glucose management of polycystic ovary syndrome.
    Gynecol Endocrinol. 2022 Nov 29:1-7. doi: 10.1080/09513590.2022.2148649.
    PubMed     Abstract available
    
    
    
35. LI M, Tian Y, Lv Y, Xu Y, et al
    The association between serum fatty acids and pregnancy in PCOS women undergoing ovulation induction.
    Gynecol Endocrinol. 2022 Nov 28:1-7. doi: 10.1080/09513590.2022.2148647.
    PubMed     Abstract available
    
    
    
36. WANG R, Miao C, Chen Y, Zhao Y, et al
    Antioxidant supplements relieve insulin resistance but do not improve lipid metabolism in women with polycystic ovary syndrome: a meta-analysis of randomized clinical trials.
    Gynecol Endocrinol. 2022 Nov 28:1-13. doi: 10.1080/09513590.2022.2148648.
    PubMed     Abstract available
    
    
    
37. AZIZ A, Shah M, Siraj S, Iqbal W, et al
    Association of vitamin D deficiency and vitamin D receptor (VDR) gene single-nucleotide polymorphism (rs7975232) with risk of preeclampsia.
    Gynecol Endocrinol. 2022 Nov 17:1-6. doi: 10.1080/09513590.2022.2146089.
    PubMed     Abstract available
    
    
    
38. GU C, Zeng X, Shi Q, Xiao Q, et al
    Androgen-secreting adult granulosa cell tumor in a woman with polycystic ovary syndrome: a case report.
    Gynecol Endocrinol. 2022 Nov 11:1-3. doi: 10.1080/09513590.2022.2143491.
    PubMed     Abstract available
    
    
    
39. YU X, Gao J, Huang Y, Zou Y, et al
    Effect of the increase rate of blood lipid concentration during pregnancy on the adverse pregnancy outcomes: a cohort study of 1051 singleton pregnancy.
    Gynecol Endocrinol. 2022 Nov 7:1-4. doi: 10.1080/09513590.2022.2138314.
    PubMed     Abstract available
    
    
    
40. CAO LY, Zhang ZQ, Liu PP, Xu DF, et al
    Aberrant BMP15/HIF-1alpha/SCF signaling pathway in human granulosa cells is involved in the PCOS related abnormal follicular development.
    Gynecol Endocrinol. 2022;38:971-977.
    PubMed     Abstract available
    
    
    
41. WANG W, Hao J, Shi Y
    IL23 suppresses proliferation and promotes apoptosis of human granulosa-like tumor cell line KGN by targeting the androgen receptor signal pathway.
    Gynecol Endocrinol. 2022;38:965-970.
    PubMed     Abstract available
    
    
    October 2022
42. WU A, Yu R, Li D, Tuo Y, et al
    Expression and mechanism of micro-ribonucleic acid-29a in chorionic villi obtained at curettage with recurrent abortion.
    Gynecol Endocrinol. 2022 Oct 27:1-5. doi: 10.1080/09513590.2022.2136159.
    PubMed     Abstract available
    
    
    
43. REGIDOR PA, Colli E
    The progestin-only pills drospirenone 4 mg and desogestrel 0.075 mg as an option for the management of dysmenorrhea and mastodynia.
    Gynecol Endocrinol. 2022 Oct 20:1-5. doi: 10.1080/09513590.2022.2134339.
    PubMed     Abstract available
    
    
    
44. MIKUS M, Vitale SG, Coric M, Zajec V, et al
    State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials.
    Gynecol Endocrinol. 2022 Oct 13:1-7. doi: 10.1080/09513590.2022.2133105.
    PubMed     Abstract available
    
    
    
45. TOLA EN, Bucak M, Togay A, Aslan Kosar P, et al
    The association between gestational diabetes mellitus and DNA damage in umbilical cord leukocytes and placental samples.
    Gynecol Endocrinol. 2022 Oct 12:1-5. doi: 10.1080/09513590.2022.2133104.
    PubMed     Abstract available
    
    
    
46. YACOUB V, Carletti V, Grilli D, Morgani C, et al
    Quality of life and sexual function analysis in a group of Italian postmenopausal women after COVID-19 vaccination.
    Gynecol Endocrinol. 2022 Oct 6:1-4. doi: 10.1080/09513590.2022.2132224.
    PubMed     Abstract available
    
    
    
47. KOSE C, Korpe B, Korkmaz V, Engin-Ustun Y, et al
    Is hemoglobin A1c valuable for predicting concurrent endometrial cancer in diabetic women with endometrial intraepithelial neoplasia?
    Gynecol Endocrinol. 2022 Oct 5:1-5. doi: 10.1080/09513590.2022.2129611.
    PubMed     Abstract available
    
    
    
48. SHI X, Chen S, Yang Y, Liu L, et al
    Laparoscopic surgeries for uterine fibroids and ovarian cysts reduce ovarian reserve via age- and surgical type-manner.
    Gynecol Endocrinol. 2022 Oct 5:1-5. doi: 10.1080/09513590.2022.2128104.
    PubMed     Abstract available
    
    
    
49. SONG H, Guan H, Tang H, Tang L, et al
    Effect of ovulation before or after intrauterine insemination on pregnancy outcome in patients with unexplained infertility or polycystic ovarian syndrome.
    Gynecol Endocrinol. 2022 Oct 2:1-5. doi: 10.1080/09513590.2022.2125952.
    PubMed     Abstract available
    
    
    September 2022
50. CAGNACCI A, Londero AP
    Hormone therapy in endometrial cancer survivors: time for a change.
    Gynecol Endocrinol. 2022 Sep 28:1-2. doi: 10.1080/09513590.2022.2128105.
    PubMed    
    
    
    
51. DE MATOS O, Ruthes EMP, Lenardt BCC, Beira de Andrade A, et al
    Relationship between postural changes, osteoarthritis and bone mineral density in postmenopausal women.
    Gynecol Endocrinol. 2022 Sep 23:1-5. doi: 10.1080/09513590.2022.2126454.
    PubMed     Abstract available
    
    
    
52. LI Y, Hao Z
    Severe ovarian hyperstimulation syndrome induced by clomiphene: a case report.
    Gynecol Endocrinol. 2022 Sep 19:1-6. doi: 10.1080/09513590.2022.2122429.
    PubMed     Abstract available
    
    
    
53. VALSAMAKIS G, Violetis O, Chatzakis C, Triantafyllidou O, et al
    Daughters of polycystic ovary syndrome pregnancies and androgen levels in puberty: a Meta-analysis.
    Gynecol Endocrinol. 2022 Sep 14:1-9. doi: 10.1080/09513590.2022.2121386.
    PubMed     Abstract available
    
    
    
54. RUAN X
    Expert consensus on fertility preservation in patients with breast cancer occurring during pregnancy.
    Gynecol Endocrinol. 2022 Sep 14:1-6. doi: 10.1080/09513590.2022.2122432.
    PubMed     Abstract available
    
    
    
55. FUENTES-CARRASCO M, Ruiz-Roman R, Saviron-Cornudella R, Perez-Roncero G, et al
    Systematic review and meta-analysis regarding maternal apelin in pregnant women with and without preeclampsia.
    Gynecol Endocrinol. 2022 Sep 12:1-10. doi: 10.1080/09513590.2022.2122433.
    PubMed     Abstract available
    
    
    
56. CETINKAYA ALTUNTAS S, Celik O, Ozer U, Colak S, et al
    Depression, anxiety, body image scores, and sexual dysfunction in patients with polycystic ovary syndrome according to phenotypes.
    Gynecol Endocrinol. 2022 Sep 11:1-7. doi: 10.1080/09513590.2022.2118708.
    PubMed     Abstract available
    
    
    
57. GRAHAM S, Archer DF, Simon JA, Ohleth KM, et al
    Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins.
    Gynecol Endocrinol. 2022 Sep 8:1-20. doi: 10.1080/09513590.2022.2118254.
    PubMed     Abstract available
    
    
    
58. ERTAS S, Unver G, Gonca Okumus Z, Yilmaz S, et al
    Maternal serum Sortilin-1 level as a potential biomarker for intrahepatic cholestasis of pregnancy.
    Gynecol Endocrinol. 2022 Sep 6:1-4. doi: 10.1080/09513590.2022.2119957.
    PubMed     Abstract available
    
    
    
59. YILDIZ C, Caner A, Oksasoglu B, Misir S, et al
    The role of cytokeratin 19 levels in the determination of endometriosis stages.
    Gynecol Endocrinol. 2022 Sep 6:1-6. doi: 10.1080/09513590.2022.2120606.
    PubMed     Abstract available
    
    
    
60. DA SILVA FR, Soares Thimoteo D, Ferraz Carbonel A, Fuchs LFP, et al
    Histomorphometric analysis of the endometrium in an ectopic model of endometriosis in mice.
    Gynecol Endocrinol. 2022 Sep 6:1-5. doi: 10.1080/09513590.2022.2119218.
    PubMed     Abstract available
    
    
    
61. YANG M, Lin S, Zheng S, Sun A, et al
    A multicenter, randomized, open, controlled trial to evaluate the efficacy of Honglilai Vaginal Cream and Premarin Vaginal Cream for Genitourinary Syndrome of Menopause in different subgroups of Chinese postmenopausal women.
    Gynecol Endocrinol. 2022 Sep 6:1-7. doi: 10.1080/09513590.2022.2118710.
    PubMed     Abstract available
    
    
    
62. QIU Y, Lin J, Xu Q, Zeng L, et al
    Effects of different doses of estrogen on ER expression and ovarian function in patients with unexplained recurrent abortion.
    Gynecol Endocrinol. 2022 Sep 5:1-5. doi: 10.1080/09513590.2022.2118707.
    PubMed     Abstract available
    
    
    
63. JI X, Chen J, Xu P, Shen S, et al
    Effect of probiotics combined with metformin on improvement of menstrual and metabolic patterns in women with polycystic ovary syndrome: a randomized clinical trial.
    Gynecol Endocrinol. 2022 Sep 5:1-5. doi: 10.1080/09513590.2022.2119219.
    PubMed     Abstract available
    
    
    
64. WU PY, Tan X, Wang M, Zheng X, et al
    Selenium supplementation for polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
    Gynecol Endocrinol. 2022 Sep 1:1-7. doi: 10.1080/09513590.2022.2118709.
    PubMed     Abstract available
    
    
    
65. BARACAT EC, Baracat MCP, Jose M SJ Jr
    Are there new insights for the definition of PCOS?
    Gynecol Endocrinol. 2022;38:703-704.
    PubMed    
    
    
    
66. SANG M, Wu Q, Tao Y, Huang F, et al
    Usage of mobile health interventions among overweight/obese PCOS patients undergoing assisted reproductive technology treatment during the COVID-19 pandemic.
    Gynecol Endocrinol. 2022;38:776-780.
    PubMed     Abstract available
    
    
    
67. YUAN X, Huang Q, Li J, Yao Q, et al
    Bone morphogenetic protein-9 maybe an important factor which improves insulin resistance in PCOS.
    Gynecol Endocrinol. 2022;38:781-789.
    PubMed     Abstract available
    
    
    August 2022
68. BI B, Jiang Y, Shi Y, Ruan F, et al
    Bazedoxifene plus conjugated estrogens improve menopausal symptoms in postmenopausal women: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2022 Aug 28:1-9. doi: 10.1080/09513590.2022.2117294.
    PubMed     Abstract available
    
    
    
69. PEREZ-LOPEZ FR, Wu JN, Yao L, Lopez-Baena MT, et al
    Apelin levels in pregnant women with and without gestational diabetes mellitus: a collaborative systematic review and meta-analysis.
    Gynecol Endocrinol. 2022 Aug 24:1-10. doi: 10.1080/09513590.2022.2114450.
    PubMed     Abstract available
    
    
    
70. ZHU L, Zhang D, Yang Y
    A case of excision of ovarian torsion necrosis due to luteoma in a female who conceived a twin pregnancy through in vitro fertilization misdiagnosed with acute appendicitis.
    Gynecol Endocrinol. 2022 Aug 24:1-4. doi: 10.1080/09513590.2022.2114448.
    PubMed     Abstract available
    
    
    
71. CAKINA S, Pek E, Ozkavak O, Kocyigit D, et al
    The role of paraoxonase and myeloperoxidase as oxidative stress markers in pregnant women with hypothyroidism.
    Gynecol Endocrinol. 2022 Aug 23:1-4. doi: 10.1080/09513590.2022.2114449.
    PubMed     Abstract available
    
    
    
72. DENG K, Fu K, Hu Y, Zhang Y, et al
    The association between serum sex hormone-binding globulin changes during progestin-primed ovarian stimulation and embryo outcomes: a retrospective cohort study.
    Gynecol Endocrinol. 2022 Aug 21:1-5. doi: 10.1080/09513590.2022.2112940.
    PubMed     Abstract available
    
    
    
73. BALIK AO, Vural F, Alpogan O, Ozogul M, et al
    The effects of testosterone on transgender males on carotid intima-media thickness and serum inflammatory markers compared within patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2022 Aug 21:1-5. doi: 10.1080/09513590.2022.2112942.
    PubMed     Abstract available
    
    
    
74. DOU X, Jin X, Chen X, Zhou Q, et al
    Bu-Shen-Ning-Xin decoction alleviates premature ovarian insufficiency (POI) by regulating autophagy of granule cells through activating PI3K/AKT/mTOR pathway.
    Gynecol Endocrinol. 2022 Aug 21:1-11. doi: 10.1080/09513590.2022.2112941.
    PubMed     Abstract available
    
    
    
75. ZAJEC V, Mikus M, Vitale SG, D'alterio MN, et al
    Current status and challenges of drug development for hormonal treatment of endometriosis: a systematic review of randomized control trials.
    Gynecol Endocrinol. 2022 Aug 15:1-8. doi: 10.1080/09513590.2022.2109145.
    PubMed     Abstract available
    
    
    
76. ZHANG C, Hu J, Wang X, Gu H, et al
    High level of homocysteine is associated with pre-eclampsia risk in pregnant woman: a meta-analysis.
    Gynecol Endocrinol. 2022 Aug 15:1-8. doi: 10.1080/09513590.2022.2110233.
    PubMed     Abstract available
    
    
    
77. ORSATTI CL, Orsatti FL, Bezerra TG, Quevedo A, et al
    Interleukin-15 are associated with insulin resistance in postmenopausal women with metabolic syndrome.
    Gynecol Endocrinol. 2022 Aug 3:1-6. doi: 10.1080/09513590.2022.2105832.
    PubMed     Abstract available
    
    
    
78. BERGA SL
    Brain phenotype in PCOS: androgens, anovulation, and gender.
    Gynecol Endocrinol. 2022;38:615-616.
    PubMed    
    
    
    
79. MIAO J, Lu J, Tang J, Lu P, et al
    Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice.
    Gynecol Endocrinol. 2022;38:656-660.
    PubMed     Abstract available
    
    
    
80. VURAL SOLAK GT, Akkus G, Solak Y, Kose S, et al
    Regional variability of modified Ferriman-Gallwey scorring in premenopausal healthy women in Southern Turkey.
    Gynecol Endocrinol. 2022;38:666-671.
    PubMed     Abstract available
    
    
    
81. GENAZZANI AD, Battipaglia C, Petrillo T, Piacquadio N, et al
    Familial diabetes predisposes PCOS patients to insulin resistance (IR), reproductive impairment and hepatic dysfunction: effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index.
    Gynecol Endocrinol. 2022;38:681-688.
    PubMed     Abstract available
    
    
    
82. MIN M, Ruan X, Wang H, Cheng J, et al
    Effect of orlistat during individualized comprehensive life-style intervention on visceral fat in overweight or obese PCOS patients.
    Gynecol Endocrinol. 2022;38:676-680.
    PubMed     Abstract available
    
    
    July 2022
83. WU D, Yu T, Shi H, Zhai J, et al
    Effect of elevated progesterone levels the day before ovulation on pregnancy outcomes in natural cycles of frozen thawed embryo transfer.
    Gynecol Endocrinol. 2022 Jul 28:1-5. doi: 10.1080/09513590.2022.2103671.
    PubMed     Abstract available
    
    
    
84. ZHAO T, Zhang Q, Xiao X, Tao X, et al
    Associations of the KiSS-1 and GPR54 genetic polymorphism with polycystic ovary syndrome in Yunnan, China.
    Gynecol Endocrinol. 2022 Jul 28:1-5. doi: 10.1080/09513590.2022.2104246.
    PubMed     Abstract available
    
    
    
85. WANG Z, Yan J, Chen H, He L, et al
    The reproductive endocrine feature and conception outcome of women with unknown etiological menstrual cycle (36-45 days) with long follicular phase.
    Gynecol Endocrinol. 2022 Jul 26:1-6. doi: 10.1080/09513590.2022.2101636.
    PubMed     Abstract available
    
    
    
86. DE ARRUDA GT, Driusso P, Rodrigues JC, de Godoy AG, et al
    Numerical rating scale for dysmenorrhea-related pain: a clinimetric study.
    Gynecol Endocrinol. 2022 Jul 19:1-5. doi: 10.1080/09513590.2022.2099831.
    PubMed     Abstract available
    
    
    
87. PAFFONI A, Cesana S, Corti L, Ballabio E, et al
    Pregnancy rate in IVF patients with unexpected poor response to ovarian stimulation.
    Gynecol Endocrinol. 2022 Jul 17:1-6. doi: 10.1080/09513590.2022.2100339.
    PubMed     Abstract available
    
    
    
88. GIANNINI A, Tebache L, Noti G, Cosimi G, et al
    Impact on ovarian reserve and fertility using carbon dioxide laser for endometriosis treatment: a systematic review.
    Gynecol Endocrinol. 2022 Jul 13:1-6. doi: 10.1080/09513590.2022.2087218.
    PubMed     Abstract available
    
    
    
89. PINGARRON SANTOFIMIA C, Lafuente Gonzalez P, Guitierrez Velez MDC, Calvente Aguilar V, et al
    Long-term use of ospemifene in clinical practice for vulvo-vaginal atrophy: end results at 12 months of follow-up.
    Gynecol Endocrinol. 2022;38:577-582.
    PubMed     Abstract available
    
    
    
90. GU M, Ruan X, Li Y, Li T, et al
    Effect on the cardiovascular independent risk factor lipoprotein(a) in overweight or obese PCOS patients with ethinyl-estradiol/drospirenone alone or plus orlistat.
    Gynecol Endocrinol. 2022;38:598-602.
    PubMed     Abstract available
    
    
    
91. AVSAR O, Derinoz N, Yilmaz F, Yilmaz M, et al
    Association between dopamine transporter gene (DAT1/SLC6A3) variants and infertility in the Turkish females.
    Gynecol Endocrinol. 2022;38:573-576.
    PubMed     Abstract available
    
    
    June 2022
92. QI Y, Hou Y, Ma M, Li X, et al
    Circulating levels of Elabela in pregnant women with missed abortion.
    Gynecol Endocrinol. 2022 Jun 27:1-4. doi: 10.1080/09513590.2022.2090539.
    PubMed     Abstract available
    
    
    
93. KORKMAZ H, Deveci CD, Alisik M, Korkmaz V, et al
    How do thiol disulfide balance and copper-ceruloplasmin levels change in women using copper intrauterine devices?
    Gynecol Endocrinol. 2022 Jun 27:1-4. doi: 10.1080/09513590.2022.2089650.
    PubMed     Abstract available
    
    
    
94. XIA J, Yang Z, Ou X, Wu G, et al
    Evaluation of the relationship between serum TSH levels and pregnancy outcomes of IVF/ICSI patients in follicular phase long-acting long protocol.
    Gynecol Endocrinol. 2022 Jun 25:1-5. doi: 10.1080/09513590.2022.2091540.
    PubMed     Abstract available
    
    
    
95. NICOLI F, Prete A, Citro F, Bertolotto A, et al
    Short sleep duration and risk of gestational diabetes.
    Gynecol Endocrinol. 2022 Jun 20:1-4. doi: 10.1080/09513590.2022.2089105.
    PubMed     Abstract available
    
    
    
96. NAPPI RE, Tiranini L
    Polycystic ovary syndrome and sexuality.
    Gynecol Endocrinol. 2022 Jun 20:1-2. doi: 10.1080/09513590.2022.2089109.
    PubMed    
    
    
    
97. ROTONDI M, Bendotti G, Croce L, Molteni M, et al
    A unique presentation of Graves' disease in a pregnant woman with severe hypothyroidism.
    Gynecol Endocrinol. 2022 Jun 20:1-5. doi: 10.1080/09513590.2022.2087216.
    PubMed     Abstract available
    
    
    
98. MENICHINI D, Ughetti C, Monari F, Di Vinci PL, et al
    Nutraceuticals and polycystic ovary syndrome: a systematic review of the literature.
    Gynecol Endocrinol. 2022 Jun 17:1-9. doi: 10.1080/09513590.2022.2089106.
    PubMed     Abstract available
    
    
    
99. OZALTIN S, Celik HG, Kar E, Baran AK, et al
    Are antral follicle count and serum anti-Mullerian hormone level, as reliable markers of ovarian reserve, affected by UV radiation?
    Gynecol Endocrinol. 2022 Jun 17:1-5. doi: 10.1080/09513590.2022.2087217.
    PubMed     Abstract available
    
    
    
100. OKYAY RE, Cetintas B, Akdoner A, Oztura I, et al
     The effect of oral contraceptive use on sympatic nerve activity in patients with polycystic ovary syndrome.
     Gynecol Endocrinol. 2022 Jun 7:1-6. doi: 10.1080/09513590.2022.2082403.
     PubMed     Abstract available
     
     
     
101. ROJEWSKA P, Meczekalski B, Bala G, Luisi S, et al
     From diagnosis to treatment of androgen-secreting ovarian tumors: a practical approach.
     Gynecol Endocrinol. 2022 Jun 1:1-6. doi: 10.1080/09513590.2022.2083104.
     PubMed     Abstract available
     
     
     
102. KIESEL L
     Endometriosis - how should we classify?
     Gynecol Endocrinol. 2022;38:449.
     PubMed    
     
     
     
103. RIBEIRO DIAS-JUNIOR A, Vieira da Motta E, Ferreira-Filho ES, Evangelista Oliveira-Junior ME, et al
     Hyperestrogenemia resulting from a granulosa cell tumor and causing pulmonary thromboembolism: a case report.
     Gynecol Endocrinol. 2022;38:531-533.
     PubMed     Abstract available
     
     
     May 2022
104. ZHAO Q, He J
     Efficacy and safety of metformin in pregnant women with polycystic ovary syndrome: a systematic review with meta-analysis of randomized and non-randomized controlled trials.
     Gynecol Endocrinol. 2022 May 27:1-11. doi: 10.1080/09513590.2022.2080194.
     PubMed     Abstract available
     
     
     
105. YALLE-VASQUEZ S, Osco-Rosales K, Nieto-Gutierrez W, Benites-Zapata V, et al
     Vitamin E supplementation improves testosterone, glucose- and lipid-related metabolism in women with polycystic ovary syndrome: a meta-analysis of randomized clinical trials.
     Gynecol Endocrinol. 2022 May 25:1-10. doi: 10.1080/09513590.2022.2079629.
     PubMed     Abstract available
     
     
     
106. DEMIRAL SEZER S, Topaloglu O
     Effects of thyroid hormones in women with gestational diabetes.
     Gynecol Endocrinol. 2022 May 23:1-4. doi: 10.1080/09513590.2022.2076832.
     PubMed     Abstract available
     
     
     
107. WANG T, Li Q
     Extratubal secondary trophoblastic implants (ESTI) following laparoscopic bilateral salpingectomy for ectopic pregnancy: problems that have been neglected for a long time.
     Gynecol Endocrinol. 2022 May 23:1-4. doi: 10.1080/09513590.2022.2078962.
     PubMed     Abstract available
     
     
     
108. PASHAEI M, Mashayekhi F, Zahiri Z, Salehi Z, et al
     miR-203a-3p, ABL1 and TP63 gene expression is altered in the endometrium of women with endometriosis.
     Gynecol Endocrinol. 2022 May 19:1-5. doi: 10.1080/09513590.2022.2076830.
     PubMed     Abstract available
     
     
     
109. LIU Q, Liu Z
     The efficacy of myo-inositol supplementation to reduce the incidence of gestational diabetes: a meta-analysis.
     Gynecol Endocrinol. 2022 May 16:1-5. doi: 10.1080/09513590.2022.2071865.
     PubMed     Abstract available
     
     
     
110. FU Y, Yang Y, Zhu L, Chen J, et al
     Effect of dietary n-6: n-3 Poly-Unsaturated fatty acids ratio on gestational diabetes mellitus: a prospective cohort.
     Gynecol Endocrinol. 2022 May 13:1-5. doi: 10.1080/09513590.2022.2073995.
     PubMed     Abstract available
     
     
     
111. JIANG H, Xu Y, Cao L
     The protective effects of S14G-humanin on gestational diabetes mellitus symptoms.
     Gynecol Endocrinol. 2022 May 10:1-5. doi: 10.1080/09513590.2022.2073348.
     PubMed     Abstract available
     
     
     
112. YANG J, Liu F, Li Y, Wu D, et al
     Forkhead box C2 is associated with insulin resistance in gestational diabetes mellitus.
     Gynecol Endocrinol. 2022 May 9:1-4. doi: 10.1080/09513590.2022.2072485.
     PubMed     Abstract available
     
     
     
113. MONARI F, Menichini D, Salerno C, Donno V, et al
     Impact of endocrine disorders on stillbirth: a prospective cohort study.
     Gynecol Endocrinol. 2022 May 4:1-5. doi: 10.1080/09513590.2022.2069747.
     PubMed     Abstract available
     
     
     April 2022
114. KAWKA-PACIORKOWSKA K, Breborowicz GH
     The role of corticoliberin concentration levels and placental CRH receptors 1 and 2 in the prolongation of pregnancy.
     Gynecol Endocrinol. 2022 Apr 27:1-5. doi: 10.1080/09513590.2022.2068521.
     PubMed     Abstract available
     
     
     
115. HELOU CM, Zhao Z, Ding T, Anderson TL, et al
     Should body mass index replace age to drive the decision for endometrial sampling in premenopausal women with abnormal uterine bleeding?
     Gynecol Endocrinol. 2022 Apr 20:1-6. doi: 10.1080/09513590.2022.2058484.
     PubMed     Abstract available
     
     
     
116. LI LH, Shi G, Pan JB, Wang CH, et al
     The expressions of matrix metalloproteinase-9, estrogen receptor, and progesterone receptor in thin endometrial tissue and their significance.
     Gynecol Endocrinol. 2022 Apr 15:1-7. doi: 10.1080/09513590.2022.2053957.
     PubMed     Abstract available
     
     
     
117. LENG T, Li X, Zhang H
     Levothyroxine treatment for subclinical hypothyroidism improves the rate of live births in pregnant women with recurrent pregnancy loss: a randomized clinical trial.
     Gynecol Endocrinol. 2022 Apr 15:1-7. doi: 10.1080/09513590.2022.2063831.
     PubMed     Abstract available
     
     
     
118. CASTELO-BRANCO C, Navarro C, Beltran E, Losa F, et al
     Black cohosh efficacy and safety for menopausal symptoms. The Spanish Menopause Society statement.
     Gynecol Endocrinol. 2022 Apr 11:1-6. doi: 10.1080/09513590.2022.2056591.
     PubMed     Abstract available
     
     
     
119. SAITO J, Kawasaki H, Adachi N, Sasaki A, et al
     Diazoxide during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum: a case report.
     Gynecol Endocrinol. 2022 Apr 9:1-3. doi: 10.1080/09513590.2022.2061453.
     PubMed     Abstract available
     
     
     
120. JIN L, Ruan X, Jin J, Wang Y, et al
     Infertile women with endometriosis possess differences in cytokine levels in various tissues.
     Gynecol Endocrinol. 2022 Apr 9:1-5. doi: 10.1080/09513590.2022.2060961.
     PubMed     Abstract available
     
     
     
121. GIORDANO LA, Giordano MV, Celia Teixeira Gomes R, Dos Santos Simoes R, et al
     Effects of clinical and metabolic variables and hormones on the expression of immune protein biomarkers in the endometrium of women with polycystic ovary syndrome and normal-cycling controls.
     Gynecol Endocrinol. 2022 Apr 8:1-8. doi: 10.1080/09513590.2022.2061454.
     PubMed     Abstract available
     
     
     
122. KAYACIK GUNDAY O, Aldemir O, Ozelci R, Dilbaz S, et al
     Supraphysiological hCG day estradiol levels can predict pregnancy-associated plasma protein A levels in maternal serum in the first trimester.
     Gynecol Endocrinol. 2022 Apr 6:1-6. doi: 10.1080/09513590.2022.2057946.
     PubMed     Abstract available
     
     
     March 2022
123. LIU Q, Wei S, Wang F
     Prothrombotic state and calcium deficiency in early pregnancy are risk factors for gestational diabetes mellitus: a retrospective cohort study.
     Gynecol Endocrinol. 2022 Mar 28:1-4. doi: 10.1080/09513590.2022.2047170.
     PubMed     Abstract available
     
     
     
124. KIZILKAYA Y, Ibanoglu MC, Kiykac Altinbas S, Engin-Ustun Y, et al
     A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms.
     Gynecol Endocrinol. 2022 Mar 23:1-4. doi: 10.1080/09513590.2022.2053956.
     PubMed     Abstract available
     
     
     
125. ZHANG Y, Xu L
     Comparative study of DHEA and letrozole induced polycystic ovary syndrome in post-pubertal rats.
     Gynecol Endocrinol. 2022 Mar 21:1-7. doi: 10.1080/09513590.2022.2052843.
     PubMed     Abstract available
     
     
     
126. ZHANG J, Huang J, He X, Li N, et al
     Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a rat model.
     Gynecol Endocrinol. 2022 Mar 14:1-6. doi: 10.1080/09513590.2022.2034147.
     PubMed     Abstract available
     
     
     
127. WANG L, Lai D
     The evaluation of ovarian function in normosmic idiopathic hypogonadotropic hypogonadism with a fibroblast growth factor receptor 1 mutation: a case report.
     Gynecol Endocrinol. 2022 Mar 11:1-4. doi: 10.1080/09513590.2022.2045580.
     PubMed     Abstract available
     
     
     
128. BADR DA, Kassem C, Carlin A, Dobrescu O, et al
     Antenatal insulin therapy in gestational diabetes mellitus: validation of the new Brugmann scores.
     Gynecol Endocrinol. 2022 Mar 11:1-5. doi: 10.1080/09513590.2022.2048296.
     PubMed     Abstract available
     
     
     
129. MAFFEI S, Franchini M, Fortunato L, Guiducci L, et al
     Long-term effects of a combination of isoflavones, agnus castus and magnolia extracts on climacteric symptoms and cardiometabolic risk profile in postmenopausal women.
     Gynecol Endocrinol. 2022 Mar 8:1-6. doi: 10.1080/09513590.2022.2047171.
     PubMed     Abstract available
     
     
     
130. TAJADA M, Dieste-Perez P, Sanz-Arenal A, Perez-Roncero G, et al
     Leukocyte telomere length in women with and without polycystic ovary syndrome: a systematic review and meta-analysis.
     Gynecol Endocrinol. 2022 Mar 7:1-7. doi: 10.1080/09513590.2022.2047922.
     PubMed     Abstract available
     
     
     
131. WU W, Xu GF, Hu YJ
     The therapeutic effect of granulocyte colony stimulating factor (G-CSF) on potential biochemical pregnancy in patients with unexplained repeated transplantation failure (RIF): a case series and literature review.
     Gynecol Endocrinol. 2022 Mar 4:1-5. doi: 10.1080/09513590.2022.2036716.
     PubMed     Abstract available
     
     
     
132. WEN Z, Qiaoqian Z, Wen S, Yonghong W, et al
     Clinical changes of leptin/ghrelin and PAI-1 levels in adolescent girls with abnormal uterine bleeding-ovulatory dysfunction.
     Gynecol Endocrinol. 2022 Mar 3:1-5. doi: 10.1080/09513590.2022.2045938.
     PubMed     Abstract available
     
     
     
133. VANNUCCINI S, Biagiotti C, Esposto MC, La Torre F, et al
     Long-term treatment of endometriosis-related pain among women seeking hormonal contraception.
     Gynecol Endocrinol. 2022 Mar 3:1-5. doi: 10.1080/09513590.2022.2047172.
     PubMed     Abstract available
     
     
     
134. CAPOZZI A, Scambia G, Lello S
     Subclinical hypothyroidism in women's health: from pre- to post-menopause.
     Gynecol Endocrinol. 2022 Mar 3:1-11. doi: 10.1080/09513590.2022.2046728.
     PubMed     Abstract available
     
     
     
135. OLUKLU D, Menekse Beser D, Uyan Hendem D, Sinaci S, et al
     Maternal serum midkine level increases in pregnant women with diabetes mellitus: a case-control study.
     Gynecol Endocrinol. 2022 Mar 3:1-4. doi: 10.1080/09513590.2022.2045937.
     PubMed     Abstract available
     
     
     
136. TONG J, Xiang L, Niu Y, Zhang T, et al
     Effect of orlistat intervention on in vitro fertilization/intracytoplasmic sperm injection outcome in overweight/obese infertile women.
     Gynecol Endocrinol. 2022;38:253-257.
     PubMed     Abstract available
     
     
     February 2022
137. WANG W, Cao YM, Cai NN, Guo Q, et al
     Influence of one-day diabetes mellitus clinic management on blood glucose control and prognosis in patients with gestational diabetes mellitus.
     Gynecol Endocrinol. 2022 Feb 21:1-5. doi: 10.1080/09513590.2022.2040474.
     PubMed     Abstract available
     
     
     
138. LIU M, Mai Z, Lin H, Li Y, et al
     Does elevated luteinizing hormone level before trigger mean premature luteinizing hormone surge in advanced-aged women undergoing mild ovarian stimulation?
     Gynecol Endocrinol. 2022 Feb 10:1-4. doi: 10.1080/09513590.2022.2037546.
     PubMed     Abstract available
     
     
     
139. RAJASEKARAN K, Malhotra N, Mahey R, Khadgawat R, et al
     Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study.
     Gynecol Endocrinol. 2022;38:140-147.
     PubMed     Abstract available
     
     
     January 2022
140. VIVEK K, Thangappazham B, Vykunta A, Kulkarni PP, et al
     Maternal serum irisin levels in normotensive and preeclamptic pregnancies: a systematic review and meta-analysis.
     Gynecol Endocrinol. 2022 Jan 10:1-8. doi: 10.1080/09513590.2021.2025217.
     PubMed     Abstract available
     
     
     
141. KONG M, Zhang H, Liu X, Ge Y, et al
     Association of maternal neutrophil count in early pregnancy with the development of gestational diabetes mellitus: a prospective cohort study in China.
     Gynecol Endocrinol. 2022 Jan 8:1-5. doi: 10.1080/09513590.2021.2025216.
     PubMed     Abstract available
     
     
     
142. LI M, Ruan X, Ju R, Min M, et al
     Is anti-Mullerian hormone a useful biomarker in the diagnosis of polycystic ovary syndrome in Chinese adolescents?
     Gynecol Endocrinol. 2022 Jan 7:1-5. doi: 10.1080/09513590.2021.2016694.
     PubMed     Abstract available
     
     
     
143. CHEDRAUI P
     The future of gynecological endocrinology.
     Gynecol Endocrinol. 2022;38:1.
     PubMed    
     
     
     December 2021
144. ZHANG J, Huang J, He X, Li N, et al
     Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a rat model.
     Gynecol Endocrinol. 2021 Dec 29:1-6. doi: 10.1080/09513590.2021.2011198.
     PubMed     Abstract available
     
     
     
145. MENDOZA N, Losa F, Palacios S
     Strategy to improve the female fertility in the general gynecologist's office: use of a nutritional supplement based on myo-inositol/D-chiro-inositol and antioxidants.
     Gynecol Endocrinol. 2021 Dec 21:1-4. doi: 10.1080/09513590.2021.2015759.
     PubMed     Abstract available
     
     
     
146. BUGGIO L, Barbara G, Facchin F, Ghezzi L, et al
     The influence of hormonal contraception on depression and female sexuality: a narrative review of the literature.
     Gynecol Endocrinol. 2021 Dec 16:1-9. doi: 10.1080/09513590.2021.2016693.
     PubMed     Abstract available
     
     
     
147. WANG L, Yao H, Shen W, Wang X, et al
     Gestational diabetes mellitus is associated with blood inflammatory indicators in a Chinese pregnant women population.
     Gynecol Endocrinol. 2021 Dec 15:1-5. doi: 10.1080/09513590.2021.2015762.
     PubMed     Abstract available
     
     
     
148. LU L, Wang Z, Zhang H, Liu T, et al
     Drynaria fortunei improves lipid profiles of elderly patients with postmenopausal osteoporosis via regulation of Notch1-NLRP3 inflammasome-mediated inflammation.
     Gynecol Endocrinol. 2021 Dec 15:1-5. doi: 10.1080/09513590.2021.2015760.
     PubMed     Abstract available
     
     
     
149. TAN X, Huang Y
     Magnesium supplementation for glycemic status in women with gestational diabetes: a systematic review and meta-analysis.
     Gynecol Endocrinol. 2021 Dec 15:1-5. doi: 10.1080/09513590.2021.1988558.
     PubMed     Abstract available
     
     
     
150. LI C, Gao C, Zhang X, Zhang L, et al
     Comparison of the effectiveness and safety of insulin and oral hypoglycemic drugs in the treatment of gestational diabetes mellitus: a meta-analysis of 26 randomized controlled trials.
     Gynecol Endocrinol. 2021 Dec 15:1-7. doi: 10.1080/09513590.2021.2015761.
     PubMed     Abstract available
     
     
     
151. MOCCIA P, Belda-Montesinos R, Monllor-Tormos A, Chedraui P, et al
     Body weight and fat mass across the menopausal transition: hormonal modulators.
     Gynecol Endocrinol. 2021 Dec 13:1-6. doi: 10.1080/09513590.2021.2004395.
     PubMed     Abstract available
     
     
     
152. PODFIGURNA A, Szeliga A, Horwat P, Maciejewska-Jeske M, et al
     Hyperthyroidism associated with struma ovarii - a case report and review of literature.
     Gynecol Endocrinol. 2021;37:1143-1150.
     PubMed     Abstract available
     
     
     
153. WANG A, Huang S, Liu M, Wang B, et al
     Clinical exome sequencing identifies novel compound heterozygous mutations of the WEE2 gene in primary infertile women with fertilization failure.
     Gynecol Endocrinol. 2021;37:1096-1101.
     PubMed     Abstract available
     
     
     November 2021
154. HERNANDEZ-JIMENEZ JL, Barrera D, Espinoza-Simon E, Gonzalez J, et al
     Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance.
     Gynecol Endocrinol. 2021 Nov 17:1-8. doi: 10.1080/09513590.2021.2003326.
     PubMed     Abstract available
     
     
     
155. VARIKASUVU SR, Perez-Lopez FR, Thangappazham B, Raj H, et al
     Effect of metformin intervention on circulating irisin levels in polycystic ovary syndrome: a systematic review and collaborative meta-analysis.
     Gynecol Endocrinol. 2021 Nov 15:1-6. doi: 10.1080/09513590.2021.1998439.
     PubMed     Abstract available
     
     
     
156. PEREZ-LOPEZ FR, Lopez-Baena MT, Varikasuvu SR, Ruiz-Roman R, et al
     Preeclampsia and gestational hypertension are associated to low maternal circulating kisspeptin levels: a systematic review and meta-analysis.
     Gynecol Endocrinol. 2021 Nov 15:1-8. doi: 10.1080/09513590.2021.2004396.
     PubMed     Abstract available
     
     
     
157. JI M, Yuan M, Jiao X, Li Q, et al
     A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
     Gynecol Endocrinol. 2021 Nov 9:1-6. doi: 10.1080/09513590.2021.2000961.
     PubMed     Abstract available
     
     
     
158. KRUSZEWSKA J, Laudy-Wiaderny H, Krzywdzinska S, Grymowicz M, et al
     Two consecutive pregnancies in a patient with premature ovarian insufficiency in the course of classic galactosemia and a review of the literature.
     Gynecol Endocrinol. 2021 Nov 3:1-4. doi: 10.1080/09513590.2021.1998437.
     PubMed     Abstract available
     
     
     October 2021
159. INDHAVIVADHANA S, Boonyachan W, Rattanachaiyanont M, Wongwananuruk T, et al
     Effectiveness of vitamin D2 supplementation on high-sensitivity C-reactive protein and other metabolic indices in menopausal Thai women: a randomized-controlled trial.
     Gynecol Endocrinol. 2021 Oct 27:1-7. doi: 10.1080/09513590.2021.1988560.
     PubMed     Abstract available
     
     
     
160. CARETTO M, Simoncini T
     Progestin or anti-estrogen treatment for endometrial cancer: choosing the best option for selected patients.
     Gynecol Endocrinol. 2021 Oct 26:1-2. doi: 10.1080/09513590.2021.1995964.
     PubMed    
     
     
     
161. DORI-DAYAN N, Cukierman-Yaffe T, Kedar N, Zemet R, et al
     Maternal glucose variability during pregnancy & birthweight percentile in women with pre-gestational diabetes.
     Gynecol Endocrinol. 2021 Oct 21:1-5. doi: 10.1080/09513590.2021.1993814.
     PubMed     Abstract available
     
     
     
162. WU H, Zheng X, Liu Y, Shen J, et al
     Hsa_circRNA_102682 is closely related to lipid metabolism in gestational diabetes mellitus.
     Gynecol Endocrinol. 2021 Oct 19:1-5. doi: 10.1080/09513590.2021.1991911.
     PubMed     Abstract available
     
     
     
163. KARAMALI M, Gholizadeh M
     The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
     Gynecol Endocrinol. 2021 Oct 19:1-5. doi: 10.1080/09513590.2021.1991910.
     PubMed     Abstract available
     
     
     
164. GRANDI G, Del Savio MC, Melotti C, Feliciello L, et al
     Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study.
     Gynecol Endocrinol. 2021 Oct 16:1-5. doi: 10.1080/09513590.2021.1991909.
     PubMed     Abstract available
     
     
     
165. SHEN Y, Li J, Tian H, Ji Y, et al
     High level of complement factor Ba within first prenatal test of gestation increases the risk of subsequent gestational diabetes: a propensity score-matched study.
     Gynecol Endocrinol. 2021 Oct 13:1-6. doi: 10.1080/09513590.2021.1989400.
     PubMed     Abstract available
     
     
     
166. LEE KW, Tan SF, Omar A, Nasir NH, et al
     Effectiveness of system-based intervention in reducing incidence of type 2 diabetes and to improve the postnatal metabolic profiles in women with gestational diabetes mellitus A: randomized controlled study.
     Gynecol Endocrinol. 2021 Oct 12:1-8. doi: 10.1080/09513590.2021.1988561.
     PubMed     Abstract available
     
     
     
167. LIAO D, Liu X, Yuan X, Feng P, et al
     Clinical evidence of the effects of carnitine supplementation on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: a systematic review and meta-analysis.
     Gynecol Endocrinol. 2021 Oct 11:1-6. doi: 10.1080/09513590.2021.1988559.
     PubMed     Abstract available
     
     
     
168. CHENG CC, Ting-An, Chang, Yang WP, et al
     First case report of papillary thyroid carcinoma arising within a functional teratoma in Graves' disease patient.
     Gynecol Endocrinol. 2021;37:955-958.
     PubMed     Abstract available
     
     
     
169. BAHCECI E, Kaya C, Karakas S, Yildiz S, et al
     Serum X-box-binding protein 1 levels in PCOS patients.
     Gynecol Endocrinol. 2021;37:920-924.
     PubMed     Abstract available
     
     
     September 2021
170. ABOSHAMA RA, Islam BA, Motaal AOA, Labib K, et al
     Effect of piroxicam administration in infertile women undergoing assisted reproductive technologies: A systematic review and meta-analysis.
     Gynecol Endocrinol. 2021;37:785-791.
     PubMed     Abstract available
     
     
     August 2021
171. NIE L, Zou H, Ma X, Cheng L, et al
     A clinical observational study on the efficacy of subcutaneous etonogestrel implants for adenomyosis in 20 patients.
     Gynecol Endocrinol. 2021;37:735-739.
     PubMed     Abstract available
     
     
     
172. DADACHANJI R, Sawant D, Patil A, Mukherjee S, et al
     Replication study of THADA rs13429458 variant with PCOS susceptibility and its related traits in Indian women.
     Gynecol Endocrinol. 2021;37:716-720.
     PubMed     Abstract available
     
     
     
173. MECZEKALSKI B, Szeliga A, Maciejewska-Jeske M, Podfigurna A, et al
     Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
     Gynecol Endocrinol. 2021;37:677-682.
     PubMed     Abstract available
     
     
     July 2021
174. BARBANTI C, Centini G, Lazzeri L, Habib N, et al
     Adenomyosis and infertility: the role of the junctional zone.
     Gynecol Endocrinol. 2021;37:577-583.
     PubMed     Abstract available
     
     
     
175. GUNTHER V, Otte SV, Freytag D, Maass N, et al
     Recurrent implantation failure - an overview of current research.
     Gynecol Endocrinol. 2021;37:584-590.
     PubMed     Abstract available
     
     
     June 2021
176. CARETTO M, Simoncini T
     The need to reduce gonadotoxicity! fertility reserve after chemotherapy for gynaecological cancer.
     Gynecol Endocrinol. 2021;37:481-482.
     PubMed    
     
     
     
177. DI TUCCI C, Galati G, Mattei G, Bonanni V, et al
     The role of alpha lipoic acid in female and male infertility: a systematic review.
     Gynecol Endocrinol. 2021;37:497-505.
     PubMed     Abstract available
     
     
     
178. PINGARRON C, de Lafuente P, Ierullo AM, Poyo Torcal S, et al
     Ospemifene in clinical practice for vulvo-vaginal atrophy: results at 3 months of follow-up of use.
     Gynecol Endocrinol. 2021;37:562-566.
     PubMed     Abstract available
     
     
     
179. CECCHINO GN, Roque M, Cerrillo M, Filho RDR, et al
     DuoStim cycles potentially boost reproductive outcomes in poor prognosis patients.
     Gynecol Endocrinol. 2021;37:519-522.
     PubMed     Abstract available
     
     
     
180. CECCHINO GN, Pacheco A, Garcia-Velasco JA
     Reproductive senescence and energetic metabolism of human luteinized granulosa cells: is it all about ATP? A prospective cohort and critical view.
     Gynecol Endocrinol. 2021;37:523-527.
     PubMed     Abstract available
     
     
     May 2021
181. WANG L, Wen X, Lv S, Tian S, et al
     Effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
     Gynecol Endocrinol. 2021;37:446-455.
     PubMed     Abstract available
     
     
     
182. ISIK G, Oktem M, Guler I, Oktem E, et al
     The impact of granulocyte colony-stimulating factor (G-CSF) on thin endometrium of an animal model with rats.
     Gynecol Endocrinol. 2021;37:438-445.
     PubMed     Abstract available
     
     
     
183. YIN XD, Xue XO, Wang JS, Yang W, et al
     Effect of Bushen Huoxue recipe on women with thin endometrial ovulation disorder and a rat model of thin endometrium resulted from kidney deficiency-related blood stasis.
     Gynecol Endocrinol. 2021;37:433-437.
     PubMed     Abstract available
     
     
     April 2021
184. PRABHAKAR P, Mahey R, Gupta M, Khadgawat R, et al
     Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles - randomized controlled trial.
     Gynecol Endocrinol. 2021;37:332-336.
     PubMed     Abstract available
     
     
     
185. ZHANG N, Zhuang L, Gai S, Shan Y, et al
     Beneficial phytoestrogenic effects of resveratrol on polycystic ovary syndromein rat model.
     Gynecol Endocrinol. 2021;37:337-341.
     PubMed     Abstract available
     
     
     March 2021
186. LI M, Jia M, Zhao X, Shi R, et al
     A new NLRP5 mutation causes female infertility and total fertilization failure.
     Gynecol Endocrinol. 2021;37:283-284.
     PubMed     Abstract available
     
     
     
187. ATASAYAN K, Yoldemir T
     The effect of PCOS status on atherosclerosis markers and cardiovascular disease risk factors in young women with vitamin D deficiency.
     Gynecol Endocrinol. 2021;37:225-229.
     PubMed     Abstract available
     
     
     
188. BULLETTI C, Allegra A, Mignini Renzini M, Vaiarelli A, et al
     How fixed versus variable gonadotropin dose during controlled ovarian stimulation could influence the management of infertility patients undergoing IVF treatment: a national Delphi consensus.
     Gynecol Endocrinol. 2021;37:255-263.
     PubMed     Abstract available
     
     
     
189. ASHRAF S, Rasool SUA, Nabi M, Ganie MA, et al
     CYP17 gene polymorphic sequence variation is associated with hyperandrogenism in Kashmiri women with polycystic ovarian syndrome.
     Gynecol Endocrinol. 2021;37:230-234.
     PubMed     Abstract available
     
     
     
190. BEZERRA ESPINOLA MS, Bilotta G, Aragona C
     Positive effect of a new supplementation of vitamin D3 with myo-inositol, folic acid and melatonin on IVF outcomes: a prospective randomized and controlled pilot study.
     Gynecol Endocrinol. 2021;37:251-254.
     PubMed     Abstract available
     
     
     February 2021
191. SHARMA P, Kaur M, Khetarpal P
     CYP19 gene rs2414096 variant and differential genetic risk of polycystic ovary syndrome: a systematic review and meta-analysis.
     Gynecol Endocrinol. 2021;37:126-131.
     PubMed     Abstract available
     
     
     
192. SHI M, Huang W, Shu L, Hou G, et al
     Research on polycystic ovary syndrome: a bibliometric analysis from 2009 to 2019.
     Gynecol Endocrinol. 2021;37:121-125.
     PubMed     Abstract available
     
     
     
193. KARAMAN S, Sabanciogullari E, Karaman E, Basaranoglu M, et al
     Indicator of early kidney injury in adolescents with polycystic ovary syndrome: Can urine NGAL level be?
     Gynecol Endocrinol. 2021;37:117-120.
     PubMed     Abstract available
     
     
     
194. ZAMANIYAN M, Peyvandi S, Heidaryan Gorji H, Moradi S, et al
     Effect of platelet-rich plasma on pregnancy outcomes in infertile women with recurrent implantation failure: a randomized controlled trial.
     Gynecol Endocrinol. 2021;37:141-145.
     PubMed     Abstract available
     
     
     January 2021
195. NAPPI RE, Palacios S, Bruyniks N, Particco M, et al
     The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy.
     Gynecol Endocrinol. 2021;37:78-82.
     PubMed     Abstract available
     
     
     
196. TAGHIZADEH S, Izadi A, Shirazi S, Parizad M, et al
     The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
     Gynecol Endocrinol. 2021;37:26-30.
     PubMed     Abstract available
     
     
     
197. DORETTO-SILVA L, Steiner ML, Veridiano JM, Petri G, et al
     White, brown, and bone marrow adipose tissue behavior in DHEA-induced PCOS mice.
     Gynecol Endocrinol. 2021;37:15-20.
     PubMed     Abstract available
     
     
     
198. BAHADUR A, Mundhra R, Kashibhatla J, Rajput R, et al
     Prevalence of metabolic syndrome among women with different PCOS phenotypes - a prospective study.
     Gynecol Endocrinol. 2021;37:21-25.
     PubMed     Abstract available
     
     
     
199. ATAKUL T, Tayyar AT, Turan OD, Celik SY, et al
     An assessment of the protective effect of gonadotropin-releasing hormone agonist and antagonist on bleomycin-induced ovarian toxicity in rats.
     Gynecol Endocrinol. 2021;37:46-50.
     PubMed     Abstract available
     
     
     
200. RADZINSKY VE, Ramazanova FU, Khamoshina MB, Azova MM, et al
     Vitamin D insufficiency as a risk factor for reproductive losses in miscarriage.
     Gynecol Endocrinol. 2021;37.
     PubMed     Abstract available
     
     
     
201. FODINA V, Dudorova A, Erenpreiss J
     Evaluation of embryo aneuploidy (PGT-A) and endometrial receptivity (ERA) testing in patients with recurrent implantation failure in ICSI cycles.
     Gynecol Endocrinol. 2021;37.
     PubMed     Abstract available
     
     
     
202. MIKHAILOVA VA, Markova KL, Belikova ME, Gzgzyan AM, et al
     T-Lymphocyte proliferative activity in early pregnancy and outside pregnancy state.
     Gynecol Endocrinol. 2021;37.
     PubMed     Abstract available
     
     
     
203. ORAZOV MR, Radzinskiy VE, Kostin IN, Gagaev CG, et al
     Endometrial asynchrony in pathogenesis of implantation impairment in women with infertility associated with endometriosis.
     Gynecol Endocrinol. 2021;37.
     PubMed     Abstract available
     
     
     
204. OB'EDKOVA KV, Kogan IY, Muller VC, Tapilskaya NI, et al
     IVF protocol efficacy in women with expected suboptimal response depending on ovary stimulation mode.
     Gynecol Endocrinol. 2021;37.
     PubMed     Abstract available
     
     
     
205. NAZARENKO TA, Martirosyan YO, Birukova AM, Korneeva IE, et al
     Outcomes of ovarian stimulation in the follicular and luteal phases of the menstrual cycle in cancer patients.
     Gynecol Endocrinol. 2021;37.
     PubMed     Abstract available
     
     
     
206. KAPUSTIN RV, Kopteeva EV, Alekseenkova EN, Tral TG, et al
     Placental expression of endoglin, placental growth factor, leptin, and hypoxia-inducible factor-1 in diabetic pregnancy and pre-eclampsia.
     Gynecol Endocrinol. 2021;37.
     PubMed     Abstract available
     
     
     
207. BAKLEICHEVA M, Bespalova O, Kovaleva I
     Features of the 1st trimester of pregnancy course with severe deficiency of 25(OH)D.
     Gynecol Endocrinol. 2021;37.
     PubMed     Abstract available
     
     
     
208. YARMOLINSKAYA M, Denisova A, Tkachenko N, Ivashenko T, et al
     Vitamin D significance in pathogenesis of endometriosis.
     Gynecol Endocrinol. 2021;37.
     PubMed     Abstract available
     
     
     
209. YARMOLINSKAYA M, Bulgakova O, Abashova E, Borodina V, et al
     The effectiveness of resveratrol in treatment of PCOS on the basis of experimental model in rats.
     Gynecol Endocrinol. 2021;37.
     PubMed     Abstract available
     
     
     
210. MAMEDALIEVA NM, Kurmanova AM, Baikoshkarova SB, Issenova S, et al
     The effectiveness of micronized progesterone in the complex therapy of 'thin endometry' syndrome.
     Gynecol Endocrinol. 2021;37.
     PubMed     Abstract available
     
     
     September 2020
211. ZHAO Y, Luan X, Wang Y
     Letrozole combined with oral contraceptives versus oral contraceptives alone in the treatment of endometriosis-related pain symptoms: a pilot study.
     Gynecol Endocrinol. 2020 Sep 16:1-5. doi: 10.1080/09513590.2020.1807502.
     PubMed     Abstract available
     
     
     June 2020
212. BATTAGLIA C, Battaglia B, Casadio P, Rizzo R, et al
     Metformin metabolic and vascular effects in normal weight hyperinsulinemic polycystic ovary syndrome patients treated with contraceptive vaginal ring. A pilot study.
     Gynecol Endocrinol. 2020 Jun 16:1-8. doi: 10.1080/09513590.2020.1770213.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: